Adagio Posts $0 Revenue, $17.8M 'Net Income' That Is Really a $23M Noncash Note Gain
ADGM sits 16% above its 52-week low of $1.5 on light trading volume (0.4× avg).
Summary
Adagio reported zero Q3 revenue and a $17.8 million net profit that is entirely a $23.0 million noncash convertible-note fair-value gain; operations lost $4.4 million and cash is down to $3.1 million. The company continues its strategic alternatives review while seeking another reverse split.
Key Events · Earnings and Guidance · ADGM
-
Zero Revenue, Paper Profit
Q3 2026 revenue was nil and the loss from operations was $4.4 million; net income of $17.8 million ($2.40 per basic share) came from a $23.0 million noncash gain on the fair value of the 13% Senior Secured Convertible Notes. Diluted EPS was a loss of $(5.13).
-
Cash Down to $3.1 Million
Cash and cash equivalents were $3.1 million at September 30, 2026, versus $17.1 million at December 31, 2025 — against $4.4 million of quarterly operating expense, a very short runway.
-
Cost Cuts Hold the Line
R&D fell to $1.8 million from $2.8 million and SG&A to $2.6 million from $2.9 million year over year, reflecting the previously announced 58% workforce reduction and the pause in European commercial activity.
-
Strategic Alternatives Still Running
The board's formal process to explore strategic alternatives, announced September 23, 2026, continues with no transaction or timeline disclosed; the PMA for the vCLAS Ventricular Ablation System remains under FDA review.
Analysis · ADGM · Industrial Applications And Services
The headline profit is accounting, not operations: $17.8 million of net income comes entirely from a $23.0 million noncash fair-value gain on the convertible notes, while the business lost $4.4 million from operations on zero revenue. Cash fell to $3.1 million from $17.1 million at year-end, which against a $4.4 million quarterly operating burn leaves very little runway — and the company is simultaneously running a strategic alternatives process and asking shareholders for another reverse split of up to 1-for-1,000 just days after completing a 1-for-30. The diluted loss of $(5.13) per share is the number that reflects the actual business.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ADGM was trading at $1.74 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.8M. The 52-week trading range was $1.50 to $50.70. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.